The medical cannabis advocacy community is standing on the brink a new era, loaded with more unknowns than it has faced in literally decades. Which makes this moment, as much as any, an appropriate moment to examine laughably self-contradictory government pronouncements and actions related to medical use of marijuana.
At a Senate Drug Hearing in April 2016, you, Senator Jeff Sessions (R – AL), president-elect Donald Trump’s nominee for Attorney General, said “I believe the Department of Justice needs to be clearer” about marijuana legalization.
As states continue to legalize cannabis, both for medical and recreational purposes, a hundred new questions are cropping up on how to handle the new infrastructure of a decriminalized United States.
As hard as it may be to turn away from the spectacle that occurs on the nightly news, there is a lot more to this voting season than the high drama of the presidential election; it is also a busy time for medical marijuana reform. And while much of the media in this regard is…
Utah Representative Gage Froerer, United Patients Group, and Sacred Roots of Healing bring professionals together for an evening of information, education and awareness on the science of cannabinoid medicine, the national political climate and the potential benefits to the people of Utah
With the recent decision by the DEA to expand the number of marijuana growers in the US, while keeping it classified as a Schedule I drug, it seems as if the legalization movement is constantly taking one step forward, only to take one step back again. Dr. Sanjay Gupta, Medical Correspondent for CNN and creator of the documentary “Weed,” has called the gesture “symbolic” meaning that while the number of growers and opportunities for research have technically expanded
Last week, the United States Drug Enforcement Agency (DEA) decided to maintain marijuana’s status as a Schedule 1 Drug under the Controlled Substance Act. By definition, substances on Schedule 1 have been determined by the U.S. Food and Drug Administration (FDA) as having “no medical use whatsoever” and are also deemed to have a “high potential for abuse.” At the same time, the DEA’s decision came with a relaxation of some of the rules regarding medical cannabis research
There’s been some recent good news among the pro-cannabis crowd: California Secretary of State Alex Padilla announced that the Adult Use Marijuana Act (AUMA) initiative is eligible for the November 8, 2016 General Election ballot.
In the wake of unspeakable tragedies like the recent terrorist attacks in Paris and San Bernardino, Americans all over the country are once again frustrated by these senseless acts of violence, and appalled at the ever-rising frequency in which they occur. Modern debates in the United States regarding the Second Amendment continue to rage, and…
It’s that time of year again when nearly 100 million Americans are expected to travel for the holidays. As in 2014, gas prices are again at an all-time low, and airlines continue to offer competitive deals, so the incentive to make the trek to visit grandma this holiday season is stronger than ever. But aside…
